Skip to content

Author

Ai-Guo Liu

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Clinical and molecular prognostic factors in newly diagnosed pediatric T-cell lymphoblastic lymphoma: a prospective, multicenter, single-arm phase 2 clinical trial

Adjusting the risk stratification based on treatment response significantly improved the overall prognosis of T-LBL, and molecular genetic risk factors might contribute to further risk stratification and provide potential therapeutic targets.

Xia Guo, Chao-Ban Wang, Yue-Jia Tang et al. · 0 citations
Open access Sep 2026

PRMT7‐mediated arginine methylation of FOXK activates Wnt/β‐catenin signalling to drive doxorubicin resistance in diffuse large B‐cell lymphoma

Abstract Background Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in diffuse large B‑cell lymphoma (DLBCL) treatment, yet its clinical efficacy is often compromised by drug resistance. Protein arginine methyltransferase 7 (PRMT7) is a methyltransferase implicated in tumourigenesis and cancer prog...

Xiao-Yan Zhao, J. Zhang, Yao Teng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.